Combination strategies with PD-1/PD-L1 blockade: current advances and future directions

M Yi, X Zheng, M Niu, S Zhu, H Ge, K Wu - Molecular cancer, 2022 - Springer
Antibodies targeting programmed cell death protein-1 (PD-1) or its ligand PD-L1 rescue T
cells from exhausted status and revive immune response against cancer cells. Based on the …

Translational applications of hydrogels

S Correa, AK Grosskopf, H Lopez Hernandez… - Chemical …, 2021 - ACS Publications
Advances in hydrogel technology have unlocked unique and valuable capabilities that are
being applied to a diverse set of translational applications. Hydrogels perform functions …

Bioengineered nanogels for cancer immunotherapy

X Ma, SJ Li, Y Liu, T Zhang, P Xue, Y Kang… - Chemical Society …, 2022 - pubs.rsc.org
Recent years have witnessed increasingly rapid advances in nanocarrier-based
biomedicine aimed at improving treatment paradigms for cancer. Nanogels serve as …

Calcium carbonate: controlled synthesis, surface functionalization, and nanostructured materials

YQ Niu, JH Liu, C Aymonier, S Fermani… - Chemical Society …, 2022 - pubs.rsc.org
Calcium carbonate (CaCO3) is an important inorganic mineral in biological and geological
systems. Traditionally, it is widely used in plastics, papermaking, ink, building materials …

[HTML][HTML] An intrinsically bioactive hydrogel with on-demand drug release behaviors for diabetic wound healing

B Hu, M Gao, KO Boakye-Yiadom, W Ho, W Yu, X Xu… - Bioactive materials, 2021 - Elsevier
Prolonged, intense inflammation and excessive oxidative stress hinder diabetic wounds
from healing normally, leading to disorders downstream including the postponement of re …

Curvature-sensing peptide inhibits tumour-derived exosomes for enhanced cancer immunotherapy

S Shin, H Ko, CH Kim, BK Yoon, S Son, JA Lee… - Nature Materials, 2023 - nature.com
Tumour-derived exosomes (T-EXOs) impede immune checkpoint blockade therapies,
motivating pharmacological efforts to inhibit them. Inspired by how antiviral curvature …

Boosting checkpoint immunotherapy with biomaterials

L Liu, Y Pan, C Zhao, P Huang, X Chen, L Rao - ACS nano, 2023 - ACS Publications
The immune checkpoint blockade (ICB) therapy has revolutionized the field of cancer
treatment, while low response rates and systemic toxicity limit its clinical outcomes. With the …

An injectable hydrogel using an immunomodulating gelator for amplified tumor immunotherapy by blocking the arginase pathway

X Ren, N Wang, Y Zhou, A Song, G Jin, Z Li, Y Luan - Acta biomaterialia, 2021 - Elsevier
Abstract Arginase 1 (ARG1) inactivates T cells by degrading L-arginine, severely reducing
the immunotherapeutic efficacy. Effectively blocking the ARG1 pathway remains a …

Nanoparticle–hydrogel superstructures for biomedical applications

Y Jiang, N Krishnan, J Heo, RH Fang… - Journal of controlled …, 2020 - Elsevier
The incorporation of nanoparticles into hydrogels yields novel superstructures that have
become increasingly popular in biomedical research. Each component of these nanoparticle …

Efficient immunotherapy of drug-free layered double hydroxide nanoparticles via neutralizing excess acid and blocking tumor cell autophagy

L Zhang, Y Jia, J Yang, L Zhang, S Hou, X Niu, J Zhu… - ACS …, 2022 - ACS Publications
Cancer immunotherapy efficacy is largely limited by the suppressive tumor immune
microenvironment (TIME) where antitumor immune cells are inhibited and tumor antigens …